Advancing unbiased, peer-reviewed medical research on clinical practice, public health, and emerging therapies. Independent. Ethical. Evidence-based.

Joined February 2025
Important new article, 'Why Statistical Power Matters When Measuring Vaccine Safety,' published in the Journal of Independent Medicine! Watch now. 🔽
Why Statistical Power Matters When Measuring Vaccine Safety In a new article published in the 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed), Dr. David Brownstein and his co-authors examine an important question: Are even the largest vaccine safety studies designed to detect rare but potentially serious adverse events? Here, Dr. Brownstein and independent researcher and statistician Hector Magno discuss the limitations of existing research, the importance of statistical power, and why further investigation is needed to better understand vaccine risks and benefits. Learn more and find the full article - links below. 🔽
18
Journal of Independent Medicine retweeted
Why Statistical Power Matters When Measuring Vaccine Safety In a new article published in the 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed), Dr. David Brownstein and his co-authors examine an important question: Are even the largest vaccine safety studies designed to detect rare but potentially serious adverse events? Here, Dr. Brownstein and independent researcher and statistician Hector Magno discuss the limitations of existing research, the importance of statistical power, and why further investigation is needed to better understand vaccine risks and benefits. Learn more and find the full article - links below. 🔽
2
2
1
9
3,321
𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 Editor-in-Chief Dr. @joevaron and Assistant Editor Dr. Adylle Varon discuss their new paper, 'How to Write a Medical Manuscript That Gets Published: A Practical Guide from the Editors’ Desk.' Read the full paper - link below. 🔽
How to Write a Medical Manuscript That Gets Published: A Practical Guide from the Editors’ Desk Writing strong research is only part of getting published. In a new 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed) article, Editor-in-Chief Dr. Joseph Varon (@joevaron) and Assistant Editor Dr. Adylle Varon break down the process of writing and submitting a medical manuscript—from choosing the right journal and formatting your paper to references, peer review, and more. Whether you’re an experienced researcher, considering publishing for the first time, or simply a curious reader who enjoys digging into scientific papers, this practical guide offers a behind-the-scenes look at how medical research makes its way from manuscript to publication. Read the full article—link below. 🔽
1
72
'Moderna’s mRNA Flu Shot Under Scrutiny' - Watch the full discussion now, and read the paper in the 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 at the link below. 🔽
Moderna’s mRNA Flu Shot Under Scrutiny On this week's IMA show, host Dr. Joseph Varon (@joevaron) was joined by Dr. Peter McCullough (@P_McCulloughMD), Nicolas Hulscher (@NicHulscher), and Dr. John Catanzaro (@Docjohnc)—authors of a new paper published in the 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed)—for a discussion on their findings about Moderna’s new mRNA influenza vaccine and the questions they raise. Watch now.
1
42
'Moderna's mRNA Flu Shot Under Scruity' - Don't miss next week's IMA show! (Wednesday, September 30th at 7pm ET). Register now and read the full paper from co-authors Dr. Peter McCullough (@P_McCulloughMD), @NicHulscher, and Dr. John Catanzaro (@Docjohnc - links below.
Replying to @Honest_Medicine
Don't miss next week's IMA show, 'Moderna's mRNA Flu Shot Under Scrutiny,' with host Dr. @joevaron and special guests Dr. Peter McCullough (@P_McCulloughMD), @NicHulscher, and Dr. John Catanzaro (@Docjohnc)—co-authors of a new paper published in the Journal of Independent Medicine (@JIndepMed), 'Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010).' Don't miss it! Wednesday, September 30 at 7pm ET.
1
1
2
163
Journal of Independent Medicine retweeted
🚨 BREAKING: Moderna’s mRNA Flu Shot Under Scrutiny Nicolas Hulscher (@NicHulscher) joins @drdrew to discuss his new paper, 'Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010),' co-authored with Dr. Peter McCullough (@P_McCulloughMD) and Dr. John A. Catanzaro (@Docjohnc) and published in the new issue of the Journal of Independent Medicine (@JIndepMed). The authors will join IMA President and Chief Medical Officer Dr. @joevaron on IMA's weekly show next Wednesday, September 30th at 7pm ET for an important discussion on the findings of their paper. Find links to register and read the full paper in the Journal - links below. 🔽
BREAKING: Our FDA Data Reanalysis Demanding MARKET WITHDRAWAL of Moderna’s mRNA Flu Shot Is Now PEER-REVIEWED and PUBLISHED The FDA’s own data now sit in the peer-reviewed record showing a 155% higher risk of UNEXPLAINED DEATH, a 515% higher risk of DISABLING REACTIONS, and an EXTREME risk-benefit imbalance. When putting benefits and harms on the same scale, we found that it’s a form of HUMAN SACRIFICE to administer mFLUSIVA. To theoretically prevent ONE flu hospitalization: 2 people suffer unexplained deaths. 278 people suffer a disabling Grade 3 reaction. 3,798 people suffer an adverse event. Our peer-reviewed study now provides Secretary Kennedy substantial scientific firepower to fulfill the demands of his supporters and HALT mRNA technology. Regulators have NO legitimate basis to ignore these horrific data. Market removal of mFLUSIVA is now REQUIRED to protect public safety.
3
18
36
7,629
NEW ISSUE of the Journal of Independent Medicine (@JIndepMed) - Read full statement and find all issues of the Journal at the links below. 🔽
Journal of Independent Medicine Features Global Scientific Perspectives in New Issue Volume 2, No. 5 brings together U.S. and international researchers to examine emerging questions in medicine, including a new reanalysis of FDA data co-authored by Dr. Peter McCullough Washington, D.C. (Sept 22, 2026) — The Independent Medical Alliance (IMA) today announced the publication of Volume 2, No. 5 of the Journal of Independent Medicine (JIM), continuing the journal’s growing international reach and its mission to advance rigorous, conflict-free scientific inquiry through collaboration among physicians, researchers, and experts from around the world. This latest issue reflects an increasingly global scientific community examining health challenges that extend far beyond national borders. Its ten articles span metabolic health and fasting, cancer biology, COVID-19 public health policy, pharmacovigilance, vaccine regulatory science, cardiovascular pathology, dermatology, medical publishing, and freedom of scientific discourse. “Medicine has always advanced when physicians and scientists learn from one another, and today that conversation must be global,” said Joseph Varon (@joevaron), MD, Editor-in-Chief of the Journal of Independent Medicine (@JIndepMed) and President and Chief Medical Officer of IMA. “The challenges facing patients do not stop at borders, and neither should scientific inquiry. As IMA continues to expand its international relationships, the Journal gives experts from different countries, specialties, and clinical environments a place to bring their observations and research into the same conversation—grounded in evidence, transparency, and a shared commitment to patients.” One of the issue’s featured original investigations is “Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010),” by Nicolas Hulscher (@NicHulscher), Peter A. McCullough, MD (@P_McCulloughMD), and John A. Catanzaro (@Docjohnc). The authors reexamine regulatory and clinical-trial data from Moderna’s (@moderna_tx) recently approved mRNA influenza vaccine, using absolute benefit-risk measures to evaluate efficacy, adverse events, evidentiary basis and question the vaccine’s overall benefit-risk profile and argue that their findings warrant further scrutiny of its continued licensure. The breadth of the new issue also underscores an important distinction at the heart of IMA’s approach to scientific independence: independent medicine does not mean working alone. “Scientific independence should expand the conversation, not narrow it,” Varon added. “When researchers with different backgrounds and perspectives can examine evidence openly, challenge assumptions, and publish findings without commercial or political pressure, science becomes stronger. That is what Honest Medicine is about, and it is exactly the kind of international scientific community we want this Journal to continue building.” Read the full statement and find Volume 2, No. 5 and all previous issues of the Journal of Independent Medicine - links below. 🔽
1
38
Editor-in-Chief of the Journal of Independent Medicine (@JIndepMed) discusses the latest issue - watch now.
NEW ISSUE OF THE JOURNAL OF INDEPENDENT MEDICINE: Independent Research. Global Perspectives. A Wide Range of Medicine. Journal of Independent Medicine (@jindepmed) Editor-in-Chief Dr. Joseph Varon (@joevaron) gives an overview of the latest issue, featuring review articles and original research on autophagy, COVID-19, mRNA flu vaccines, spike protein and blood clots, integrative cancer care, melatonin and hair loss, and more. Watch now. Links to the full statement and all issues of the Journal below. 🔽
26
Journal of Independent Medicine retweeted
NEW ISSUE OF THE JOURNAL OF INDEPENDENT MEDICINE: Independent Research. Global Perspectives. A Wide Range of Medicine. Journal of Independent Medicine (@jindepmed) Editor-in-Chief Dr. Joseph Varon (@joevaron) gives an overview of the latest issue, featuring review articles and original research on autophagy, COVID-19, mRNA flu vaccines, spike protein and blood clots, integrative cancer care, melatonin and hair loss, and more. Watch now. Links to the full statement and all issues of the Journal below. 🔽
Journal of Independent Medicine Features Global Scientific Perspectives in New Issue Volume 2, No. 5 brings together U.S. and international researchers to examine emerging questions in medicine, including a new reanalysis of FDA data co-authored by Dr. Peter McCullough Washington, D.C. (Sept 22, 2026) — The Independent Medical Alliance (IMA) today announced the publication of Volume 2, No. 5 of the Journal of Independent Medicine (JIM), continuing the journal’s growing international reach and its mission to advance rigorous, conflict-free scientific inquiry through collaboration among physicians, researchers, and experts from around the world. This latest issue reflects an increasingly global scientific community examining health challenges that extend far beyond national borders. Its ten articles span metabolic health and fasting, cancer biology, COVID-19 public health policy, pharmacovigilance, vaccine regulatory science, cardiovascular pathology, dermatology, medical publishing, and freedom of scientific discourse. “Medicine has always advanced when physicians and scientists learn from one another, and today that conversation must be global,” said Joseph Varon (@joevaron), MD, Editor-in-Chief of the Journal of Independent Medicine (@JIndepMed) and President and Chief Medical Officer of IMA. “The challenges facing patients do not stop at borders, and neither should scientific inquiry. As IMA continues to expand its international relationships, the Journal gives experts from different countries, specialties, and clinical environments a place to bring their observations and research into the same conversation—grounded in evidence, transparency, and a shared commitment to patients.” One of the issue’s featured original investigations is “Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010),” by Nicolas Hulscher (@NicHulscher), Peter A. McCullough, MD (@P_McCulloughMD), and John A. Catanzaro (@Docjohnc). The authors reexamine regulatory and clinical-trial data from Moderna’s (@moderna_tx) recently approved mRNA influenza vaccine, using absolute benefit-risk measures to evaluate efficacy, adverse events, evidentiary basis and question the vaccine’s overall benefit-risk profile and argue that their findings warrant further scrutiny of its continued licensure. The breadth of the new issue also underscores an important distinction at the heart of IMA’s approach to scientific independence: independent medicine does not mean working alone. “Scientific independence should expand the conversation, not narrow it,” Varon added. “When researchers with different backgrounds and perspectives can examine evidence openly, challenge assumptions, and publish findings without commercial or political pressure, science becomes stronger. That is what Honest Medicine is about, and it is exactly the kind of international scientific community we want this Journal to continue building.” Read the full statement and find Volume 2, No. 5 and all previous issues of the Journal of Independent Medicine - links below. 🔽
1
7
2
16
5,480
Journal of Independent Medicine retweeted
What If the Conventional Model of Inflammatory Bowel Disease Is Wrong? Patients with Crohn’s disease and ulcerative colitis are often told their condition is genetic, autoimmune, or simply of unknown cause—leaving medications and surgery as the primary options. Last week, IMA Senior Fellow Dr. JP Saleeby and gut health specialist @joshdech_health joined us to discuss their new paper published in the 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed). Their findings challenge those assumptions and propose a new framework for understanding IBD—one that could reshape how medicine approaches prevention, treatment, and future research. Watch the full discussion and read the paper - links below. 🔽
3
5
28
8,417
Journal of Independent Medicine retweeted
Inflammatory Bowel Disease Is Not Genetically Determined, Not Classically Autoimmune, and Not Idiopathic: A Critical Reframing of Pathogenesis Read article now in the Journal of Independent Medicine (@JIndepMed): journalofindependentmedicine…
1
5
707
Journal of Independent Medicine retweeted
'The Hidden Drivers of Inflammatory Bowel Disease' On this week's show, host and IMA Senior Fellow Dr. Yusuf (JP) Saleeby was joined by gut health specialist @joshdech_health, his co-author on a new paper published in the 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed), for an important discussion on the hidden drivers of Crohn’s disease and ulcerative colitis, emerging research into environmental factors and the microbiome, and what this evolving understanding could mean for patients and clinicians. Watch now.
2
5
14
4,619
Journal of Independent Medicine retweeted
Inside the Latest Issue of the Journal of Independent Medicine Journal of Independent Medicine (@jindepmed) Editor-in-Chief Dr. Joseph Varon (@joevaron) and Assistant Editor Dr. Adylle Varon discuss the latest issue—from a heartfelt tribute to attorney Warner Mendenhall (@MendenhallFirm) and an essay reflecting on 250 years of American medicine to studies examining vaccine safety, Canada’s MAID program, and much more. Watch now. Find all articles in the latest issue - link below.
Journal of Independent Medicine Marks America’s 250th With New Edition Advancing Independent, Patient-Centered Science Volume 2, Issue 4 reflects on what American medicine has built, what it has lost and what must be restored—while presenting new research across medical ethics, critical care, informed consent and chronic disease Washington, D.C. (July 16, 2026) The Independent Medical Alliance (IMA) today announced the publication of Volume 2, Issue 4 of the Journal of Independent Medicine (@JIndepMed), continuing to advance rigorous, conflict-free, double-blind peer-reviewed science. As the United States commemorates its 250th anniversary, the new issue features timely and notable medical research and observations, including: • The Quiet Expansion of Death: Canada’s MAID Program and the Moral Fatigue of Modern Medicine • Two Hundred Fifty Years of American Medicine: What We Built, What We Lost, and What Must Be Restored • Vaccine Mandates and Evidence-Based Medicine: A Narrative Review • Why Statistical Power Matters When Measuring Vaccine Safety And much more from America’s leading independent doctors, researchers, and healthcare professionals. “Over the past 250 years, American medicine has produced extraordinary discoveries and saved countless lives, but progress cannot be measured by innovation alone,” said Joseph Varon (@joevaron), MD, Editor-in-Chief of the Journal of Independent Medicine and president and chief medical officer of IMA. “It must also be measured by whether physicians are free to exercise clinical judgment, patients are fully informed and science can be examined without financial or political pressure. The Journal of Independent Medicine is helping restore those roots by providing a rigorous forum where evidence leads, honest debate is welcomed and the doctor-patient relationship remains at the center of care. This eighth issue demonstrates that independent science is not a retreat from progress—it is how medicine moves forward with integrity for the next generation.” The new edition includes ‘Two Hundred Fifty Years of American Medicine: What We Built, What We Lost, and What Must Be Restored,’ a historical reflection by IMA Senior Director of Communications @LynneKristensen and Dr. Varon examining American medicine’s scientific achievements alongside changes in clinical autonomy, informed consent and the physician-patient relationship. The article complements IMA’s broader Medicine at 250 Years project, which reflects on the history of medicine while working to restore honest, independent and patient-centered care for the next generation. Read full statement, find the new issue of the Journal and all articles, and learn about IMA's Medicine at 250 Years series - links below. 🔽
1
9
20
7,247
Journal of Independent Medicine retweeted
Journal of Independent Medicine Marks America’s 250th With New Edition Advancing Independent, Patient-Centered Science Volume 2, Issue 4 reflects on what American medicine has built, what it has lost and what must be restored—while presenting new research across medical ethics, critical care, informed consent and chronic disease Washington, D.C. (July 16, 2026) The Independent Medical Alliance (IMA) today announced the publication of Volume 2, Issue 4 of the Journal of Independent Medicine (@JIndepMed), continuing to advance rigorous, conflict-free, double-blind peer-reviewed science. As the United States commemorates its 250th anniversary, the new issue features timely and notable medical research and observations, including: • The Quiet Expansion of Death: Canada’s MAID Program and the Moral Fatigue of Modern Medicine • Two Hundred Fifty Years of American Medicine: What We Built, What We Lost, and What Must Be Restored • Vaccine Mandates and Evidence-Based Medicine: A Narrative Review • Why Statistical Power Matters When Measuring Vaccine Safety And much more from America’s leading independent doctors, researchers, and healthcare professionals. “Over the past 250 years, American medicine has produced extraordinary discoveries and saved countless lives, but progress cannot be measured by innovation alone,” said Joseph Varon (@joevaron), MD, Editor-in-Chief of the Journal of Independent Medicine and president and chief medical officer of IMA. “It must also be measured by whether physicians are free to exercise clinical judgment, patients are fully informed and science can be examined without financial or political pressure. The Journal of Independent Medicine is helping restore those roots by providing a rigorous forum where evidence leads, honest debate is welcomed and the doctor-patient relationship remains at the center of care. This eighth issue demonstrates that independent science is not a retreat from progress—it is how medicine moves forward with integrity for the next generation.” The new edition includes ‘Two Hundred Fifty Years of American Medicine: What We Built, What We Lost, and What Must Be Restored,’ a historical reflection by IMA Senior Director of Communications @LynneKristensen and Dr. Varon examining American medicine’s scientific achievements alongside changes in clinical autonomy, informed consent and the physician-patient relationship. The article complements IMA’s broader Medicine at 250 Years project, which reflects on the history of medicine while working to restore honest, independent and patient-centered care for the next generation. Read full statement, find the new issue of the Journal and all articles, and learn about IMA's Medicine at 250 Years series - links below. 🔽
1
5
1
10
8,876
Journal of Independent Medicine retweeted
New Research Challenges the Lancet Paper Behind Australia’s COVID Booster Push A Lancet-published study claimed COVID-19 vaccines sharply reduced deaths among elderly Australians, including deaths from cancer, dementia, and heart disease. New research published in the Journal of Independent Medicine (@JIndepMed) shows why that claim fails a basic plausibility test. Here, co-authors Clare Pain and Dr. Mark Jones discuss the findings of their research. Links to learn more and read the full paper below. 🔽
13
46
4
98
12,484
Journal of Independent Medicine retweeted
Chlorine Dioxide as an Adjunctive Treatment in Three Veterinary Cases: A Case Series Read now in the Journal of Independent Medicine: journalofindependentmedicine…
1
2
5
1,548